Therapy News and Research

RSS

New nanotechnology-based test can detect and profile prostate cancers even in microscopic amounts

Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers - even in microscopic amounts.

2 Feb 2023

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Patients with glioblastoma - the deadliest type of primary brain tumor - may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.

2 Feb 2023

Combined glucocorticoid steroids and statin therapy may be safer for the treatment of preterm birth

Potentially life-saving steroids commonly given to preterm babies also increase the risk of long-term cardiovascular problems, but a new study in rats has found that if given in conjunction with statins, their positive effects remain while the potential negative side-effects are 'weeded out'.

2 Feb 2023

A review of interventions and support options for long COVID patients returning to work

Researchers discuss interventions and support for individuals with long COVID to help them return to normal activity levels.

2 Feb 2023

Exploring long- and short-term mortalities among COVID-19 patients

Researchers assessed the longer- and short-term all-cause mortalities among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients.

2 Feb 2023

Dual antiplatelet therapy for minor or a warning stroke is underused especially among women

Despite evidence that starting two blood-thinning medications shortly after a minor stroke or a warning stroke (transient ischemic attack - TIA) may prevent a second – possibly more serious – clot-caused stroke within a few months, the treatment regimen is underused especially among women, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

2 Feb 2023

The safety and tolerability of Remdesivir in children affected by COVID-19

Researchers reported findings of a multicenter study conducted across ten hospitals in Italy to investigate the safety of RDV in children affected by COVID-19.

2 Feb 2023

What is the impact of anticancer therapy on patients with hematologic malignancies and COVID-19?

Researchers performed a systematic review and meta-analysis following the PRISMA guidelines.

2 Feb 2023

Trial shows the benefit of using a celery seed-derived medication after clot treatment in stroke patients

People who had an ischemic (clot-caused) stroke and were treated with a clot-busting medication and/or mechanical clot removal and also received butylphthalide, a medication initially compounded from celery seed, experienced milder neurological symptoms with better functioning at three months after the stroke, compared to stroke patients who had their clots treated but received a placebo medication, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

2 Feb 2023

Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for breast cancer drug

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer.

1 Feb 2023

Medicaid expansion in Southern states leads to earlier and more comprehensive treatment of breast cancer

Patients diagnosed with invasive breast cancer in a Southern state that expanded access to Medicaid were more likely to receive treatment and less likely to be diagnosed with advanced-stage disease, according to new research published in the Journal of the American College of Surgeons.

1 Feb 2023

Brain injuries greatly reduced in infants with congenital heart disease

Recent advances in newborn heart surgery have greatly reduced brain injuries in infants with congenital heart disease, according to a 20-year study by scientists at UCSF Benioff Children's Hospitals and British Columbia Children's Hospital (BCCH).

1 Feb 2023

Deep-learning based filter removes false positives, improves the accuracy of cancer diagnosis

Next-generation cancer strategies rely on next-generation gene sequencing (NGS), which paves the way for new techniques and tools to detect mutations and determine patient therapy.

1 Feb 2023

MD Anderson and Federation Bio collaborate to design and manufacture a synthetic microbial consortium

The University of Texas MD Anderson Cancer Center and Federation Bio today announced a strategic collaboration to design and manufacture a complex, synthetic microbial consortium with the goal of expanding the number of cancer patients who respond to immunotherapy.

1 Feb 2023

CuSTOM; Creating a healthier society by accelerating the translation of organoid technology

In this interview, we speak to Magdalena Kasendra at the CuSTOM Accelerator, about the organoid technology and how it has the power the revolutionize healthcare.

From Society for Laboratory Automation and Screening (SLAS) 1 Feb 2023

Analysis of rebound virus suggests two separate reservoirs of latent HIV in patients

When people living with HIV take antiviral therapy (ART), their viral loads are driven so low that a standard blood test cannot detect the virus.

1 Feb 2023

New discovery about "killer torpedoes" may be the next breakthrough in cancer treatment

In our body, we have both an innate immune system and an immune system that is developed throughout life. Part of the innate immune system consists of so-called NK cells.

31 Jan 2023

Study demonstrates an age cutoff heuristic in oncology

Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.

31 Jan 2023

Adding veliparib to chemotherapy can extend progression-free survival in patients with “BRCA-like” breast cancer

Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times in patients with triple-negative breast cancer (TNBC) that has a "BRCA-like" phenotype.

31 Jan 2023

New technique offers a two-prong approach to attacking cancers

When noninvasive sound waves break apart tumors, they trigger an immune response in mice. By breaking down the cell wall "cloak," the treatment exposes cancer cell markers that had previously been hidden from the body's defenses, researchers at the University of Michigan have shown.

31 Jan 2023

Therapy News and Research

New nanotechnology-based test can detect and profile prostate cancers even in microscopic amounts

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Combined glucocorticoid steroids and statin therapy may be safer for the treatment of preterm birth

A review of interventions and support options for long COVID patients returning to work

Exploring long- and short-term mortalities among COVID-19 patients

Dual antiplatelet therapy for minor or a warning stroke is underused especially among women

The safety and tolerability of Remdesivir in children affected by COVID-19

What is the impact of anticancer therapy on patients with hematologic malignancies and COVID-19?

Trial shows the benefit of using a celery seed-derived medication after clot treatment in stroke patients

Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for breast cancer drug

Medicaid expansion in Southern states leads to earlier and more comprehensive treatment of breast cancer

Brain injuries greatly reduced in infants with congenital heart disease

Deep-learning based filter removes false positives, improves the accuracy of cancer diagnosis

MD Anderson and Federation Bio collaborate to design and manufacture a synthetic microbial consortium

CuSTOM; Creating a healthier society by accelerating the translation of organoid technology

Analysis of rebound virus suggests two separate reservoirs of latent HIV in patients

New discovery about "killer torpedoes" may be the next breakthrough in cancer treatment

Study demonstrates an age cutoff heuristic in oncology

Adding veliparib to chemotherapy can extend progression-free survival in patients with “BRCA-like” breast cancer

New technique offers a two-prong approach to attacking cancers

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News